Expertise in
4
conditions

Eve Maubec

Bobigny, FR 
Expertise in
4
conditions
Bobigny, FR 

Overview

Eve Maubec practices practicing medicine in Bobigny, France.

Ms. Maubec is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Cutaneous T-Cell Lymphoma (CTCL), and T-Cell Lymphoma.

She is actively involved in clinical research, co-authoring 100 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Bobigny, France
Other Locations
Paris, France
Marseille, France
Nice, France
Villejuif, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Impact of the IL4I1 Enzyme Expression in Patients With Cutaneous Melanoma: Prognostic Value and/or Role in Resistance to Current Immunotherapy and Targeted Therapy
Impact of the IL4I1 Enzyme Expression in Patients With Cutaneous Melanoma: Prognostic Value and/or Role in Resistance to Current Immunotherapy and Targeted Therapy
Enrollment Status: Completed
Publish Date: May 20, 2026
Intervention Type: Biological
Study Phase: Not Applicable
Nivolumab in Combination With High Dose Radiotherapy at Varied Tumor Sites in Advanced Melanoma and no Prior Antitumoral Treatment
Nivolumab in Combination With High Dose Radiotherapy at Varied Tumor Sites in Advanced Melanoma and no Prior Antitumoral Treatment
Enrollment Status: Completed
Publish Date: November 15, 2023
Intervention Type: Radiation, Biological
Study Drug: Nivolumab
Study Phase: Phase 2
Evaluation of Cobimetinib + Vemurafenib Combination Treatment in Patients With Brain Metastasis BRAFV600 Mutated Cutaneous Melanoma
Evaluation of Cobimetinib + Vemurafenib Combination Treatment in Patients With Brain Metastasis BRAFV600 Mutated Cutaneous Melanoma
Enrollment Status: Completed
Publish Date: January 27, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

100 Total Publications

Efficacy and safety of anti-PD-1 plus lenvatinib in mucosal melanoma: a real-world series.
Efficacy and safety of anti-PD-1 plus lenvatinib in mucosal melanoma: a real-world series.
Journal: Annales de dermatologie et de venereologie
Published: October 23, 2025

Frequently Asked Questions about Eve Maubec

Is Eve Maubec a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Eve Maubec is classified as an Distinguished expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Eve Maubec participate in research or clinical trials?

Yes. Eve Maubec has published 100 articles and abstracts on conditions like Melanoma. You can view a list of Eve Maubec's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Maubec's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile